رجوع
نطاق اليوم
KWD 22.40
KWD 23.82
نطاق 52 أسبوعًا
KWD 13.63
KWD 31.00
حجم التداول
1,996,081
متوسط 50 يوم / 200 يوم
KWD 25.19
/
KWD 23.80
الإغلاق السابق
KWD 24.18
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 1720.7 | 0.3 |
| P/B | 7.7 | 2.9 |
| ROE % | 0.5 | 3.7 |
| Net Margin % | 0.2 | 3.8 |
| Rev Growth 5Y % | 12.7 | 10.0 |
| D/E | 0.6 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 29.330
+27.2%
Low: KWD 20.000
High: KWD 35.000
مكرر الربحية المستقبلي
50.2
ربحية السهم المستقبلية
KWD 0.482
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
980 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 0.970
KWD 0.505 – KWD 1.435
|
1.6 B | 2 |
| FY2027 |
KWD 0.646
KWD 0.515 – KWD 0.730
|
1.1 B | 7 |
| FY2026 |
KWD 0.482
KWD 0.387 – KWD 0.576
|
980 M | 7 |
النقاط الرئيسية
Revenue grew 12.68% annually over 5 years — strong growth
ROE of 0.46% is below average
Generating 43.74M in free cash flow
P/E of 1720.69 — premium valuation
Cash machine — converts 2665.27% of earnings into free cash flow
Capital efficient — spends only 7.69% of revenue on capex
النمو
Revenue Growth (5Y)
12.68%
Revenue (1Y)13.04%
Earnings (1Y)N/A
FCF Growth (3Y)144.44%
الجودة
Return on Equity
0.46%
ROIC-0.67%
Net Margin0.19%
Op. Margin-0.61%
الأمان
Debt / Equity
0.63
Current Ratio2.35
Interest Coverage0.00
التقييم
P/E Ratio
1720.69
P/B Ratio7.68
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.04% | Revenue Growth (3Y) | 14.10% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12.68% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 871.91M | Net Income (TTM) | 1.64M |
| ROE | 0.46% | ROA | 0.23% |
| Gross Margin | 53.97% | Operating Margin | -0.61% |
| Net Margin | 0.19% | Free Cash Flow (TTM) | 43.74M |
| ROIC | -0.67% | FCF Growth (3Y) | 144.44% |
| Safety | |||
| Debt / Equity | 0.63 | Current Ratio | 2.35 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 1720.69 | P/B Ratio | 7.68 |
| P/S Ratio | 3.24 | PEG Ratio | -15.10 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.82B | Enterprise Value | 2.77B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 871.91M | 771.32M | 669.77M | 598.11M | 540.80M |
| Net Income | 1.64M | -20.39M | -63.20M | -110.39M | -144.27M |
| EPS (Diluted) | 0.01 | -0.17 | -0.54 | -0.96 | -1.39 |
| Gross Profit | 470.58M | 426.83M | 365.22M | 341.06M | 317.75M |
| Operating Income | -5.34M | -30.11M | -72.00M | -111.20M | -143.66M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 720.92M | 676.49M | 580.31M | 568.71M | 440.65M |
| Total Liabilities | 353.19M | 336.42M | 278.53M | 282.06M | 154.65M |
| Shareholders' Equity | 367.73M | 340.07M | 301.79M | 286.65M | 286.00M |
| Total Debt | 233.15M | 225.36M | 174.46M | 173.38M | 0.0 |
| Cash & Equivalents | 286.36M | 254.16M | 216.89M | 208.59M | 256.42M |
| Current Assets | 352.44M | 326.05M | 298.62M | 294.57M | 327.98M |
| Current Liabilities | 150.13M | 130.35M | 127.09M | 129.56M | 118.10M |